MediGene's vision is the expansion of the potentials in medicine by means of utilizing biotechnology in a responsible manner.MediGene applies state-of-the-art technologies in the development of innovative drugs for the treatment of cancer and autoimmune diseases and pursues the strategy of integrating all core areas of a modern biopharmaceuticals company from research to drug development and commercialization.

MediGene is the first industrial partner of and engaged in a joint project on the development of anti-allergy and anti-cancer vaccines.